Drinkenburg
Wilhelmus Drinkenburg, Molenschot NL
Patent application number | Description | Published |
---|---|---|
20090312416 | TREATMENT OF SLEEP-WAKE DISORDERS - This invention is directed to a method of treating Excessive daytime Sleepiness (EDS) in a subject, comprising the step of administering a therapeutically effective amount of a compound of Formula (I): Formula (I) or a pharmaceutically acceptable salt or ester thereof wherein Rx is a member selected from the group consisting of hydrogen, lower alkyl of 1 to 8 carbon atoms, halogen selected from F, Cl, Br and I, alkoxy containing 1 to 3 carbon atoms, nitro, hydroxy, trifluoromethyl, and thioalkoxy containing 1 to 3 carbon atoms; x is an integer of 1 to 3, with the proviso that R may be the same or different when x is 2 or 3; R | 12-17-2009 |
20120199995 | APPARATUS AND METHOD FOR FORMATION OF AN ENERGIZED OPHTHALMIC DEVICE FOR LIGHT THERAPY - This invention discloses methods and apparatus for providing an ophthalmic lens with light source capable of providing specific bandwidths of light to an eye of a wearer. In some embodiments, an ophthalmic lens is cast molded from a silicone hydrogel and an energy source and light source encapsulated within the ophthalmic lens. | 08-09-2012 |
20120203310 | SPECTACLES FOR LIGHT THERAPY - The present invention provides for eyeglasses to deliver light therapy to the wearer. The eyeglass lenses or frames feature an embedded light source in logical and electrical communication with power, sensors, processors, and other components contained within the eyeglasses. | 08-09-2012 |
20120215291 | LIGHT THERAPY SYSTEM INCLUDING SPECTACLE FRAMES AND CONTACT LENSES - The present invention provides for eyeglasses used together with contact lenses to deliver light therapy to the wearer. The eyeglass lenses or frames feature an embedded light source in logical and electrical communication with power, sensors, processors, and other components contained within the eyeglasses. The eyeglass lenses or frames project light into complimentary contact lenses which refract, diffract or reflect light into the wearer's eyes. | 08-23-2012 |
Wilhelmus Helena Drinkenburg, Molenschot NL
Patent application number | Description | Published |
---|---|---|
20090281099 | SUBSTITUTED PYRAZINONE DERIVATIVES FOR USE AS A MEDICINE - The present invention concerns substituted pyrazinone derivatives according to the general Formula (I) | 11-12-2009 |
Wilhelmus Helena Ignatius Maria Drinkenburg, Molenschot NL
Patent application number | Description | Published |
---|---|---|
20080269251 | Substituted Pyrazinone Derivatives as Alpha2C-Adrenoreceptor Antagonists - The present invention concerns substituted pyrazinone derivatives according to the general Formula (I) | 10-30-2008 |
20090111801 | SUBSTITUTED PYRAZINONE DERIVATIVES FOR USE AS A MEDICINE - The present invention concerns substituted pyrazinone derivatives according to the general Formula (I), a pharmaceutically acceptable acid or base addition salt thereof, a stereochemically isomeric form thereof, an N-oxide form thereof or a quaternary ammonium salt thereof, wherein the variables are defined in Claim | 04-30-2009 |
20100105694 | SUBSTITUTED PYRAZINONE DERIVATIVES FOR USE AS A MEDICINE - The present invention concerns substituted pyrazinone derivatives according to the general Formula (I) a pharmaceutically acceptable acid or base addition salt thereof, a stereochemically isomeric form thereof, an N-oxide form thereof or a quaternary ammonium salt thereof, wherein the variables are defined in claim | 04-29-2010 |
Wilhelmus H.i.m. Drinkenburg, Molenschot NL
Patent application number | Description | Published |
---|---|---|
20130137764 | Treatment of Sleep-Wake Disorders - This invention is directed to a method of treating Excessive daytime Sleepiness (EDS) in a subject, comprising the step of administering a therapeutically effective amount of a compound of Formula (I): Formula (I) or a pharmaceutically acceptable salt or ester thereof wherein Rx is a member selected from the group consisting of hydrogen, lower alkyl of 1 to 8 carbon atoms, halogen selected from F, Cl, Br and I, alkoxy containing 1 to 3 carbon atoms, nitro, hydroxy, trifluoromethyl, and thioalkoxy containing 1 to 3 carbon atoms; x is an integer of 1 to 3, with the proviso that R may be the same or different when x is 2 or 3; R | 05-30-2013 |
20140350098 | TREATMENT OF SLEEP-WAKE DISORDERS - This invention is directed to a method of treating Excessive daytime Sleepiness (EDS) in a subject, comprising the step of administering a therapeutically effective amount of a compound of Formula (I): Formula (I) or a pharmaceutically acceptable salt or ester thereof wherein Rx is a member selected from the group consisting of hydrogen, lower alkyl of 1 to 8 carbon atoms, halogen selected from F, Cl, Br and I, alkoxy containing 1 to 3 carbon atoms, nitro, hydroxy, trifluoromethyl, and thioalkoxy containing 1 to 3 carbon atoms; x is an integer of 1 to 3, with the proviso that R may be the same or different when x is 2 or 3; R1 and R2 can be the same or different from each other and are independently selected from the group consisting of hydrogen, lower alkyl of 1 to 8 carbon atoms, aryl, arylalkyl, cycloalkyl of 3 to 7 carbon atoms; R1 and R2 can be joined to form a 5 to 7-membered heterocycle substituted with a member selected from the group consisting of hydrogen, alkyl, and aryl groups, wherein the cyclic compound can comprise 1 to 2 nitrogen atoms and 0 to 1 oxygen atom, wherein the nitrogen atoms are not directly connected with each other or with the ox en atom. | 11-27-2014 |